Alfonso Carmona
12 Papers
144 Citations
Alfonso Carmona is an academic researcher. The author has contributed to research in topics: Vaccination & Reactogenicity. The author has an hindex of 8, co-authored 12 publications.
Chat about Author
Papers
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.
Alfonso Carmona,Felix Omeñaca,Juan C. Tejedor,Jose Manuel Merino,Tejaswini Vaman,Ilse Dieussaert,Paul Gillard,Javier Arístegui +7 more
TL;DR: It is suggested that a first dose of AS03(B)-adjuvanted A/H1N1/2009 vaccine containing 1.9microg HA in children 6-35 months old is highly immunogenic and that the overall reactogenicity profile is acceptable although reactions including fever tend to increase after a second dose.
101
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women.
José Garcia-Sicilia,Tino F. Schwarz,Alfonso Carmona,Klaus Peters,Jean-Elie Malkin,Phu My Tran,Ulrich Behre,Enrique B. Iturbe,Grégory Catteau,Florence Thomas,Kurt Dobbelaere,Dominique Descamps,Gary Dubin +12 more
TL;DR: Results from this study support coadministration of the HPV-16/18 AS04-adjuvanted vaccine with dTpa-IPV vaccine in females aged 10-18 years.
42
Quadrivalent Influenza Vaccine Prevents Illness and Reduces Healthcare Utilization Across Diverse Geographic Regions During Five Influenza Seasons: A Randomized Clinical Trial.
Ghassan Dbaibo,Arshad Amanullah,Carine Claeys,Allen Izu,Varsha K. Jain,Pope Kosalaraksa,Luis Rivera,Jyoti Soni,Emad Yanni,Khalequ Zaman,Beatriz Acosta,Miguel Ariza,Maria L. Arroba Basanta,Ashish Bavdekar,Alfonso Carmona,Luis Cousin,Jasur Danier,Adolfo Diaz,Javier Díez-Domingo,Ener Cagri Dinleyici,Saul N. Faust,José Garcia-Sicilia,Grace D. Gomez-Go,Maria L. A. Gonzales,Mustafa Hacimustafaoglu,Stephen M. Hughes,Teresa Jackowska,Shashi Kant,Marilla G. Lucero,Josep Mares Bermudez,Federico Martinón-Torres,May Montellano,Roman Prymula,Thanyawee Puthanakit,Renata Ruzkova,Iwona Sadowska-Krawczenko,Henryk Szymański,Angels Ulied,Wayne Woo,Anne Schuind,Bruce L. Innis +40 more
TL;DR: This research presents a novel probabilistic approach that allows us to assess the importance of knowing the carrier and removal status of canine coronavirus as a source of infection for other animals.
34
Immunogenicity and safety of AS03-adjuvanted H1N1 pandemic vaccines in children and adolescents.
José Garcia-Sicilia,Paul Gillard,Alfonso Carmona,Juan C. Tejedor,Javier Arístegui,Jose Manuel Merino,Ulrich Behre,Adrian Caplanusi,Tejaswini Vaman,Ilse Dieussaert +9 more
TL;DR: Both dosages of the AS03-adjuvanted A/H1N1/2009 pandemic influenza vaccines were highly immunogenic and well-tolerated in children and adolescents.
33
13-valent pneumococcal conjugate vaccine given with meningococcal C-tetanus toxoid conjugate and other routine pediatric vaccinations: immunogenicity and safety.
Federico Martinón-Torres,Francisco Gimenez-Sanchez,Alejandra Gurtman,Enrique Bernaola,Javier Díez-Domingo,Alfonso Carmona,Mohinder Sidhu,Denise A. Sarkozy,William C. Gruber,Emilio A. Emini,Daniel A. Scott +10 more
TL;DR: PCV13 is highly immunogenic with a favorable safety profile and does not interfere with MnCC-TT, and other childhood vaccines were noninferior when concomitantly administered with PCV13 compared withPCV7.
27